494 related articles for article (PubMed ID: 24582144)
1. The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: a prospective cohort study.
Verdonck-de Leeuw IM; Buffart LM; Heymans MW; Rietveld DH; Doornaert P; de Bree R; Buter J; Aaronson NK; Slotman BJ; Leemans CR; Langendijk JA
Radiother Oncol; 2014 Mar; 110(3):422-8. PubMed ID: 24582144
[TBL] [Abstract][Full Text] [Related]
2. An international phase 3 trial in head and neck cancer: quality of life and symptom results: EORTC 24954 on behalf of the EORTC Head and Neck and the EORTC Radiation Oncology Group.
Bottomley A; Tridello G; Coens C; Rolland F; Tesselaar ME; Leemans CR; Hupperets P; Licitra L; Vermorken JB; Van Den Weyngaert D; Truc G; Barillot I; Lefebvre JL
Cancer; 2014 Feb; 120(3):390-8. PubMed ID: 24452673
[TBL] [Abstract][Full Text] [Related]
3. Head and neck specific Health Related Quality of Life scores predict subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study.
Osthus AA; Aarstad AK; Olofsson J; Aarstad HJ
Oral Oncol; 2011 Oct; 47(10):974-9. PubMed ID: 21856209
[TBL] [Abstract][Full Text] [Related]
4. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Antunes HS; Herchenhorn D; Small IA; Araújo CM; Viégas CM; Cabral E; Rampini MP; Rodrigues PC; Silva TG; Ferreira EM; Dias FL; Ferreira CG
Radiother Oncol; 2013 Nov; 109(2):297-302. PubMed ID: 24044799
[TBL] [Abstract][Full Text] [Related]
5. EORTC Quality of Life Questionnaire Head and Neck (H&N)-35 scores from H&N squamous cell carcinoma patients obtained at diagnosis and at 6, 9 and 12 months following diagnosis predict 10-year overall survival.
Aarstad HJ; Østhus AA; Aarstad HH; Lybak S; Aarstad AKH
Eur Arch Otorhinolaryngol; 2019 Dec; 276(12):3495-3505. PubMed ID: 31529149
[TBL] [Abstract][Full Text] [Related]
6. Analysis of dysphagia in advanced-stage head-and-neck cancer patients: impact on quality of life and development of a preventive swallowing treatment.
Carmignani I; Locatello LG; Desideri I; Bonomo P; Olmetto E; Livi L; Le Saec O; Coscarelli S; Mannelli G
Eur Arch Otorhinolaryngol; 2018 Aug; 275(8):2159-2167. PubMed ID: 29978259
[TBL] [Abstract][Full Text] [Related]
7. Quality-of-life (QOL) outcomes in patients with head and neck squamous cell carcinoma (HNSCC) treated with intensity-modulated radiation therapy (IMRT) compared to three-dimensional conformal radiotherapy (3D-CRT): evidence from a prospective randomized study.
Rathod S; Gupta T; Ghosh-Laskar S; Murthy V; Budrukkar A; Agarwal J
Oral Oncol; 2013 Jun; 49(6):634-42. PubMed ID: 23562564
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer.
Bascoul-Mollevi C; Gourgou S; Galais MP; Raoul JL; Bouché O; Douillard JY; Adenis A; Etienne PL; Juzyna B; Bedenne L; Conroy T
Eur J Cancer; 2017 Oct; 84():239-249. PubMed ID: 28829992
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in long-term survivors after high-dose chemoradiotherapy followed by surgery in esophageal cancer.
Hurmuzlu M; Aarstad HJ; Aarstad AK; Hjermstad MJ; Viste A
Dis Esophagus; 2011 Jan; 24(1):39-47. PubMed ID: 20819100
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment quality of life as a prognostic factor for early survival and functional outcomes in patients with head and neck cancer.
Yang CJ; Roh JL; Kim MJ; Lee SW; Kim SB; Choi SH; Nam SY; Kim SY
Qual Life Res; 2016 Jan; 25(1):165-74. PubMed ID: 26156405
[TBL] [Abstract][Full Text] [Related]
11. Tumor site and disease stage as predictors of quality of life in head and neck cancer: a prospective study on patients treated with surgery or combined therapy with surgery and radiotherapy or radiochemotherapy.
Veldhuis D; Probst G; Marek A; Noack V; Ural A; Adamietz I; Dazert S; Minovi A
Eur Arch Otorhinolaryngol; 2016 Jan; 273(1):215-24. PubMed ID: 25575842
[TBL] [Abstract][Full Text] [Related]
12. Impact of neoadjuvant chemoradiotherapy on health-related quality of life in long-term survivors of esophageal or junctional cancer: results from the randomized CROSS trial.
Noordman BJ; Verdam MGE; Lagarde SM; Shapiro J; Hulshof MCCM; van Berge Henegouwen MI; Wijnhoven BPL; Nieuwenhuijzen GAP; Bonenkamp JJ; Cuesta MA; Plukker JTM; Spillenaar Bilgen EJ; Steyerberg EW; van der Gaast A; Sprangers MAG; van Lanschot JJB;
Ann Oncol; 2018 Feb; 29(2):445-451. PubMed ID: 29126244
[TBL] [Abstract][Full Text] [Related]
13. Survival outcomes with concurrent chemoradiation for elderly patients with locally advanced head and neck cancer according to the National Cancer Data Base.
Amini A; Jones BL; McDermott JD; Serracino HS; Jimeno A; Raben D; Ghosh D; Bowles DW; Karam SD
Cancer; 2016 May; 122(10):1533-43. PubMed ID: 26969811
[TBL] [Abstract][Full Text] [Related]
14. Level of distress predicts subsequent survival in successfully treated head and neck cancer patients: a prospective cohort study.
Aarstad HJ; Osthus AA; Olofsson J; Aarstad AK
Acta Otolaryngol; 2014 Feb; 134(2):211-9. PubMed ID: 24256042
[TBL] [Abstract][Full Text] [Related]
15. Health-related quality of life in long-term survivors of unresectable locally advanced non-small cell lung cancer.
Ran J; Wang J; Bi N; Jiang W; Zhou Z; Hui Z; Liang J; Feng Q; Wang L
Radiat Oncol; 2017 Dec; 12(1):195. PubMed ID: 29197373
[TBL] [Abstract][Full Text] [Related]
16. Trends in the 15D health-related quality of life over the first year following diagnosis of head and neck cancer.
Aro K; Bäck L; Loimu V; Saarilahti K; Rogers S; Sintonen H; Roine R; Mäkitie A
Eur Arch Otorhinolaryngol; 2016 Aug; 273(8):2141-50. PubMed ID: 26216625
[TBL] [Abstract][Full Text] [Related]
17. Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer.
de Vries J; Bras L; Sidorenkov G; Festen S; Steenbakkers RJHM; Langendijk JA; Witjes MJH; van der Laan BFAM; de Bock GH; Halmos GB
Oral Oncol; 2020 Dec; 111():105020. PubMed ID: 33045628
[TBL] [Abstract][Full Text] [Related]
18. Prediction of survival by pretreatment health-related quality-of-life scores in a prospective cohort of patients with head and neck squamous cell carcinoma.
Østhus AA; Aarstad AK; Olofsson J; Aarstad HJ
JAMA Otolaryngol Head Neck Surg; 2013 Jan; 139(1):14-20. PubMed ID: 23329087
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life 10 years after oesophageal cancer surgery.
Schandl A; Lagergren J; Johar A; Lagergren P
Eur J Cancer; 2016 Dec; 69():43-50. PubMed ID: 27816831
[TBL] [Abstract][Full Text] [Related]
20. General health-related quality of life scores from head and neck squamous cell carcinoma patients obtained throughout the first year following diagnosis predicted up to 10-year overall survival.
Aarstad HJ; Østhus AA; Aarstad HH; Lybak S; Aarstad AKH
Eur Arch Otorhinolaryngol; 2018 Jan; 275(1):207-217. PubMed ID: 29159750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]